Sam A. Coulibaly
Ouagadougou, Burkina Faso
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Integrated lipidomic and transcriptomic profiling of the host response in human malaria.
Journal: Genome biology
Published: December 06, 2025
The impact of interethnic lipidomic variation in falciparum malaria.
Journal: The Journal of infection
Published: July 01, 2024
Plasmodium falciparum gametocyte production correlates with genetic markers of parasite replication but is not influenced by experimental exposure to mosquito biting.
Journal: EBioMedicine
Published: November 17, 2023
Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.
Journal: The Lancet. Microbe
Published: October 05, 2023
Impact of Plasmodium falciparum infection on DNA methylation of circulating immune cells.
Journal: Frontiers in genetics
Published: March 31, 2023
Safety and immunogenicity of BK-SE36 in a blinded, randomized, controlled, age de-escalating phase Ib clinical trial in Burkinabe children.
Journal: Frontiers in immunology
Published: June 26, 2022
Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso.
Journal: Antimicrobial agents and chemotherapy
Published: June 01, 2021
G6PD Polymorphisms and Hemolysis After Antimalarial Treatment With Low Single-Dose Primaquine: A Pooled Analysis of Six African Clinical Trials.
Journal: Frontiers in genetics
Published: December 23, 2020
Integrative genomic analysis reveals mechanisms of immune evasion in P. falciparum malaria.
Journal: Nature communications
Published: January 24, 2020
Efficacy of Olyset Duo, a bednet containing pyriproxyfen and permethrin, versus a permethrin-only net against clinical malaria in an area with highly pyrethroid-resistant vectors in rural Burkina Faso: a cluster-randomised controlled trial.
Journal: Lancet (London, England)
Published: February 06, 2018
Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.
Journal: PloS one
Published: August 22, 2017
Last Updated: 09/26/2026